2008
DOI: 10.1016/j.bmcl.2008.05.075
|View full text |Cite
|
Sign up to set email alerts
|

Imidazopyridines as VLA-4 integrin antagonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
6
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 8 publications
0
6
0
Order By: Relevance
“…As the incorporation of the CF 3 group into cyclopropanes represents important structural modifications which can improve the bioactivity of the target molecules, the synthesis of CF 3 -cyclopropanes has received a great deal of attention from the synthetic community. Traditional approaches such as intramolecular cyclization of CF 3 -substrates suffer from tedious procedures to prepare the starting materials. , Recently, Baran found that trifluoro­methyl­cyclo­propyl sulfinate salt is a good reagent for a radical reaction to afford CF 3 -cyclopropanes .…”
mentioning
confidence: 99%
“…As the incorporation of the CF 3 group into cyclopropanes represents important structural modifications which can improve the bioactivity of the target molecules, the synthesis of CF 3 -cyclopropanes has received a great deal of attention from the synthetic community. Traditional approaches such as intramolecular cyclization of CF 3 -substrates suffer from tedious procedures to prepare the starting materials. , Recently, Baran found that trifluoro­methyl­cyclo­propyl sulfinate salt is a good reagent for a radical reaction to afford CF 3 -cyclopropanes .…”
mentioning
confidence: 99%
“…The stability proves to be appropriate for biological investigations, as the t 1/2 value for the aqueous degradation was determined to be 36.5 h at room temperature. The stability and bioavailability of these structures is also supported by the fact that interestingly, the rather unique bromocyclobutenaminone core has been incorporated both in the α4β1/α4β7 integrin antagonist prodrug, Zaurategrast [24,25], which progressed to phase II clinical trials [26], as well as in related compounds [22].…”
Section: Resultsmentioning
confidence: 99%
“…The sequence furnished ethoxyenone (12) in moderate yield, which was transformed by acidic hydrolysis to 2,2-dimethylcyclobutane-1,3-dione (13) in high yield [18][19][20][21]. Next, dione 13 was condensed with various amines in the presence of AcOH as catalyst at 65 °C to generate the desired enaminones (14a-e) in moderate yields [18,22]. Bromination of all enaminones In continuation of our interests in finding new MurA inhibitors and in the use of the cyclobutyl motif in drug discovery [6,[15][16][17], here we describe cyclobutenaminone derivatives with carefully-modulated electrophilic character as new warheads for covalently targeting the Cys115 residue in the active site of MurA.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations